Weight Loss and Obesity Management Market, by Product & Services (Drugs, Supplements, Equipment, and Services), by Age Group (Children, Adults, and Geriatric), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S

Weight Loss and Obesity Management Market, by Product & Services (Drugs, Supplements, Equipment, and Services), by Age Group (Children, Adults, and Geriatric), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Obesity refers to body fat and body mass index above 25 (overweight) and 30 (obese), respectively. It is one of the most prevalent disease conditions across the world. It affects individuals in developed, emerging, and undeveloped regions. The weight loss and obesity management services involve the use of certain products such as dietary supplements, medications, surgical interventions, and fitness equipment. According to the World Health Organization, when the Body-Mass-Index is greater than or equal to 25, the person is categorized as overweight; and BMI index above 30 is classified as obese.
Market Dynamics
Increasing incidence of obesity in developed and developing economies of the world is expected to assist growth of the weight loss and obesity management market during the forecast period. For instance, according to the WHO reports published in 2021, around 35.8 million disabilities worldwide are caused due to obesity. Furthermore, increasing research and development, and adoption of strategies such as collaborations and development of novel products by market players to expand their geographical footprint is expected to drive growth of the weight loss and obesity management market.
Key features of the study:
This report provides in-depth analysis of the global weight loss and obesity management market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global weight loss and obesity management market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, VIVUS Inc., Herbalife Ltd., Apollo Endosurgery (U.S.), Amer Sports, Brunswick Corporation, Cybex International, Duke Products & Services & Fitness Center, Ethicon Inc., Equinox, Inc., Johnson & Johnson Services, Inc., Kellogg Company, Life Time Fitness Inc., Medtronic, and NutriSystem, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up gradation, market expansion, and marketing tactics
The global weight loss and obesity management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global weight loss and obesity management market
Detailed Segmentation:
Global Weight Loss and Obesity Management Market, By Product & Services:
Drugs
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Equipment
Fitness Equipment
Surgical Equipment
Services
Consulting Service
Online Weight Loss Programs
Others
Global Weight Loss and Obesity Management Market, By Age Group:
Children
Adults
Geriatrics
Global Weight Loss and Obesity Management Market, By Region:
North America
By Product & Services:
Drugs
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Equipment
Fitness Equipment
Surgical Equipment
Services
Consulting Service
Online Weight Loss Programs
Others
By Age Group:
Children
Adults
Geriatrics
By Country:
U.S.
Canada
Latin America
By Product & Services:
Drugs
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Equipment
Fitness Equipment
Surgical Equipment
Services
Consulting Service
Online Weight Loss Programs
Others
By Age Group:
Children
Adults
Geriatrics
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product & Services:
Drugs
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Equipment
Fitness Equipment
Surgical Equipment
Services
Consulting Service
Online Weight Loss Programs
Others
By Age Group:
Children
Adults
Geriatrics
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product & Services:
Drugs
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Equipment
Fitness Equipment
Surgical Equipment
Services
Consulting Service
Online Weight Loss Programs
Others
By Age Group:
Children
Adults
Geriatrics
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product & Services:
Drugs
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Equipment
Fitness Equipment
Surgical Equipment
Services
Consulting Service
Online Weight Loss Programs
Others
By Age Group:
Children
Adults
Geriatrics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product & Services:
Drugs
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Equipment
Fitness Equipment
Surgical Equipment
Services
Consulting Service
Online Weight Loss Programs
Others
By Age Group:
Children
Adults
Geriatrics
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Novo Nordisk A/S *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Takeda Pharmaceutical Company Ltd
Eisai Co., Ltd.
F. Hoffmann-La Roche Ltd
VIVUS Inc.
Herbalife Ltd.
Apollo Endosurgery (U.S.)
Amer Sports
Brunswick Corporation
Cybex International
Ethicon, Inc.
Equinox, Inc.
Johnson & Johnson Services, Inc.
Kellogg Company
Life Time Fitness Inc.
Medtronic
NutriSystem, Inc.
“*” marked represents similar segmentation in other categories in the respective section.